Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rod-Cone Dystrophy”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableLooking for participantsNCT06445322
What this trial is testing

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Who this might be right for
Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more
Ascidian Therapeutics, Inc 50
Not applicableStudy completedNCT04459780
What this trial is testing

Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis

Who this might be right for
Psoriasis
Pierre Fabre Dermo Cosmetique 40
Not applicableLooking for participantsNCT05355415
What this trial is testing

Adaptive Optics Imaging of Outer Retinal Diseases

Who this might be right for
Retinal DegenerationAge-Related Macular DegenerationRetinitis Pigmentosa+7 more
Food and Drug Administration (FDA) 100
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Not applicableWithdrawnNCT05077956
What this trial is testing

Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis

Who this might be right for
Relapsing Multiple SclerosisMultiple Sclerosis
Providence Health & Services
Not applicableLooking for participantsNCT02617966
What this trial is testing

Rod and Cone Mediated Function in Retinal Disease

Who this might be right for
Retinal DegenerationRetinitis PigmentosaStargardt's Disease
National Eye Institute (NEI) 500
Testing effectiveness (Phase 2)Looking for participantsNCT06789445
What this trial is testing

Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Who this might be right for
Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)Usher Syndrome+6 more
BlueRock Therapeutics 54
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Not applicableLooking for participantsNCT05534347
What this trial is testing

Angiogenic Biomarkers in Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Ended earlyNCT02338973
What this trial is testing

Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)

Who this might be right for
Inherited Ophthalmic DiseasesInherited Retinal Degeneration
National Eye Institute (NEI) 4
Testing effectiveness (Phase 2)Looking for participantsNCT06467344
What this trial is testing

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

Who this might be right for
Stargardt DiseaseCone Rod DystrophyJuvenile Macular Degeneration+1 more
Ascidian Therapeutics, Inc 15
Testing effectiveness (Phase 2)UnknownNCT01773278
What this trial is testing

Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Who this might be right for
Smith-Lemli-Opitz SyndromeCone-Rod DystrophyHearing Loss
University of Colorado, Denver 100
Large-scale testing (Phase 3)Study completedNCT01091727
What this trial is testing

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Sunnybrook Health Sciences Centre 57
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Testing effectiveness (Phase 2)Looking for participantsNCT07807111
What this trial is testing

Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy

Who this might be right for
Retinitis Pigmentosa (RP)Rod Cone Dystrophy
SparingVision 27
Not applicableLooking for participantsNCT05294978
What this trial is testing

EyeConic: Qualification for Cone-Optogenetics

Who this might be right for
Retinal Dystrophies
Institute of Molecular and Clinical Ophthalmology Basel 1,000
Not applicableLooking for participantsNCT07341763
What this trial is testing

Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment

Who this might be right for
Retinitis Pigmentosa (RP)Rod Cone DystrophyVisually Impaired Persons+8 more
University of Waterloo 20
Not applicableEnded earlyNCT03561922
What this trial is testing

Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS

Who this might be right for
Retinal DegenerationInherited Retinal Dystrophy Primarily Involving Sensory Retina
Retina Implant AG 2
Not applicableStudy completedNCT01497379
What this trial is testing

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Who this might be right for
Retinal DegenerationRetinitis Pigmentosa
Retina Implant AG 2
Testing effectiveness (Phase 2)Study completedNCT02110225
What this trial is testing

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)

Who this might be right for
Retinitis Pigmentosa
Dompé Farmaceutici S.p.A 50
Next Page